| Citation: |
LI Ling, GAO Yingchuan, ZHU Xiaodong, QU Song, LIANG Zhenqiang, LIANG Xia, FU Qingguo, LI Wenzhuang. Clinical Outcomes and Dose-volume Analysis of Local Recurrence after Intensitymodulated Radiation Therapy for Nasopharyngeal Carcinoma Patients[J]. Cancer Research on Prevention and Treatment, 2014, 41(04): 353-357. DOI: 10.3971/j.issn.1000-8578.2014.04.015
|
| [1] |
Xia P, Fu KK, Wong GW, et al. Comparison of treatment plans involving intensity-modulated radiotherapy for nasopharyngeal carcinoma[J]. Int J Radiat Oncol Biol Phys,2000,48(2):329-37.
|
| [2] |
Cheng JC, Chao KS, Low D. Comparison of intensity modulated radiation therapy (IMRT) treatment techniques for nasopharyngeal carcinoma[J]. Int J Cancer,2001,96(2):126-31.
|
| [3] |
Hunt MA, Zelefsky MJ, Wolden S, et al. Treatment planning and delivery of intensity-modulated radiation therapy for primary nasopharynx cancer[J]. Int J Radiat Oncol Biol Phys,2001,49(3):623-32.
|
| [4] |
Li YP, Zhou YJ,Wu Y,et al.Theoretical anslysis of optimal dosefractionation of intensity-modulated radiotherapy in head and neck squamous cell carcinoma[J].Zhong Liu Fang Zhi Yan Jiu,2014,41(2):148-52.[黎艳萍,周亚娟,吴媛,等.头颈部鳞 癌调强放疗最佳分割方案的理论分析[J]??肿瘤防治研究， 20 14,41(2??:148-52.]
|
| [5] |
Kwong DL, Pow EH, Sham JS, et al. Intensity-modulated radiotherapy for early-stage nasopharyngeal carcinoma: a prospective study on disease control and preservation of salivary function[J]. Cancer,2004,101(7):1584-93.
|
| [6] |
Kam MK, Teo PM, Chau RM, et al. Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience[J]. Int J Radiat Oncol Biol Phys,2004,60(5):1440-50.
|
| [7] |
Kwong DL, Sham JS, Leung LH, et al. Preliminary results of radiation dose escalation for locally advanced nasopharyngeal carcinoma[J]. Int J Radiat Oncol Biol Phys,2006,64(2):374-81.
|
| [8] |
Lee N, Harris J, Garden A S, et al. Intensity-modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: radiation therapy oncology group phaseⅡtrial 02 25[J]. JCO,2009,27(22):3684-90.
|
| [9] |
Lin S, Pan J, Han L, et al. Nasopharyngeal carcinoma treated with reduced-volume intensity-modulated radiation therapy: report on the 3-year outcome of a prospective series[J]. Int J Radiat Oncol Biol Phys,2009,75(4):1071-8.
|
| [10] |
Tham IW, Hee SW, Yeo RM, et al. Treatment of nasopharyngeal carcinoma using intensity-modulated radiotherapy-the national cancer centre singapore experience[J]. Int J Radiat Oncol Biol Phys,2009,75(5): 1481-6.
|
| [11] |
MA J, MAI HQ, MO HY, et al. Patterns of treatment failure after primary radiotherapy in patients with nasopharyngeal carcinoma[J]. Chin J Cancer,2000,19(11):1016-8. [马骏, 麦海强, 莫浩元, 等.鼻咽癌放射治疗失败原因分析[ J ] . 癌 症,2000,19(11):1016-8.]
|
| [12] |
YI Jl, Gao L, Huang XD, et al. The failure patterns of nasopharyngeal carcinoma treated by radiation therapy[J]. Chin J Radiat Oncol,2004,13(3):145-8. [易俊林,高黎,黄晓 东,等.鼻咽癌放射治疗的失败模式[J].中华放射肿瘤学杂 志,2004,13(3):145-8.]
|
| [13] |
Dawson LA, Anzai Y, Marsh L, et al. Patterns of local-regional recurrence following parotid-sparing conformal and segmental intensity-modulated radiotherapy for head and neck cancer[J]. Int J Radiat Oncol Biol Phys,2000,46(5):1117-26.
|
| [14] |
Dirix P, Nuyts S. Evidence-based organ-sparing radiotherapy in head and neck cancer[J]. Lancet Oncol,2010,11(1):85-91.
|
| [15] |
Cannon DM, Lee NY. Recurrence in region of spared parotid gland after definitive intensity-modulated radiotherapy for head and neck cancer[J]. Int J Radiat Oncol Biol Phys,2008,70(3):660-5.
|
| [16] |
Pigott K, Dische S, Saunders MI. Where exactly does failure occur after radiation in head and neck cancer?[J]. Radiother Oncol,1995,37(1):17-9.
|
| [17] |
Lee N, Xia P, Quivey JM, et al. Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience[J]. Int J Radiat Oncol Biol Phys,2002,53(1):12-22.
|
| [18] |
Chao KS, Ozyigit G, Tran BN, et al. Patterns of failure in patients receiving definitive and postoperative IMRT for head-and-neck cancer[J]. Int J Radiat Oncol Biol Phys,2003,55(2):312-21.
|
| [19] |
Xia YF, Li MZ, Huang B, et al. Cellular radiobiological characteristics of human nasopharyngeal carcinoma cell lines[J]. Ai Zheng,2001,20(7):683-7. [夏云飞,李满枝,黄冰,等. 14株 (亚 株) 人鼻咽癌细胞的放射生物特性[J]. 癌症,2001,20(7):683-7.]
|
| [20] |
Chao KS, Bosch WR, Mutic S, et al. A novel approach to overcome hypoxic tumor resistance: Cu-ATSM-guided intensitymodulated radiation therapy[J]. Int J Radiat Oncol Biol Phys,2001,49(4):1171-82.
|
| [21] |
Teo P, Lee WY, Yu P. The prognostic significance of parapharyngeal tumour involvement in nasopharyngeal carcinoma[J]. Radiother Oncol,1996,39(3):209-21.
|
| [22] |
Hsiung CY, Wu JM, Wang CJ, et al. Attenuation of radiation dose by the skull base bone in patients with nasopharyngeal carcinoma: clinical importance[J]. Radiology,2001,218(2):457-63.
|
| [1] | KONG Yan, DONG Qian, LI Shuguang, XU Jinrui, ZHAO Xiaohan, DENG Wenzhao, SHEN Wenbin. Influence of Local Tumor Factors and Radiotherapy Dose on Prognosis of Clinical Stage T1-4N0M0 Esophageal Squamous Cell Carcinoma[J]. Cancer Research on Prevention and Treatment, 2025, 52(3): 225-232. DOI: 10.3971/j.issn.1000-8578.2025.24.0721 |
| [2] | XIA Lili, ZHU Xinyi, ZHANG Xiwei, LI Zhengjiang, LIU Shaoyan, LU Haizhen, AN Changming. Predictive Value of Depth of Invasion of Tongue Squamous Cell Carcinoma for Cervical Lymph Node Metastasis and Prognosis[J]. Cancer Research on Prevention and Treatment, 2022, 49(7): 675-681. DOI: 10.3971/j.issn.1000-8578.2022.21.1460 |
| [3] | LI Haiyan, ZHOU Xuan, CHEN Yunqing, JI Huihui, SHI Weiping, WANG Chengqin, XIANG Fenggang. Expression of KIF3A in Different Gastric Mucosal Lesions, Metastatic Lymph Nodes and Its Relationship with Metastasis and Prognosis of Gastric Adenocarcinoma[J]. Cancer Research on Prevention and Treatment, 2018, 45(12): 985-990. DOI: 10.3971/j.issn.1000-8578.2018.18.0627 |
| [4] | ZHAO Ruihua, JIANG Wenjing, ZHANG Weijie, CAO Xinguang. Metastasis?associated Lung Adenocarcinoma Transcript1(MALAT1) Expression in Middle Thoracic Esophageal Squamous Cell Cancer Tissues and Its Relationship with Prognosis[J]. Cancer Research on Prevention and Treatment, 2015, 42(12): 1227-1230. DOI: 10.3971/j.issn.1000-8578.2015.12.012 |
| [5] | LV Minhao, QIN Li, LI Juntao, GUO Xuhui, LIU Fawen, CUI Shude, ZHANG Hengwei. 原发性乳腺癌分子分型与新辅助化疗疗效及预后的相关性[J]. Cancer Research on Prevention and Treatment, 2015, 42(08): 782-788. DOI: 10.3971/j.issn.1000-8578.2015.08.007 |
| [6] | Zhen Chanjun, Zhou Zhiguo, Song Yuzhi, Qiao Xueying. Analysis of Therapeutic Effect and Prognosis of Radiotherapy for Patients with Esophageal Carcinoma with Supraclavicular Lymph Node Metastasis[J]. Cancer Research on Prevention and Treatment, 2013, 40(01): 90-94. DOI: 10.3971/j.issn.1000-8578.2013.01.023 |
| [7] | LI Na, LI Shan-shan, ZHANG Hong-yan, XUAN Xiao-yan, ZHENG Xian-zhao, WANG Feng, YAN Ai-hua. Effects of KISS-1 Transfection on Tumor Growth of Nude Mice[J]. Cancer Research on Prevention and Treatment, 2010, 37(02): 136-140. DOI: 10.3971/j.issn.1000-8578.2010.02.004 |
| [8] | LI Na, LI Shan-shan, ZHANG Hong-yan, XUAN Xiao-yan, ZHENG Xian-zhao, WANG Feng, YAN Ai-hua. Construction of Eukaryotic Expression Plasmid pcDNA3.1-KISS-1 and Its Metastasis Inhibiting Effect to EC1 Cells[J]. Cancer Research on Prevention and Treatment, 2009, 36(04): 265-269. DOI: 10.3971/j.issn.1000-8578.2009.04.002 |
| [9] | GAO Zhao-hua. Analysis of Clinicopathologic Characteristics and Prognosis of Colorectal Cancer without Lymph Node Metastasis[J]. Cancer Research on Prevention and Treatment, 2008, 35(04): 272-274. DOI: 10.3971/j.issn.1000-8578.2697 |
| [10] | Huang jinqiu, . The significance of tumor angiogenesis in the invasion metastasis and judging the prognosis of gastric carcinoma[J]. Cancer Research on Prevention and Treatment, 1998, 25(6): 441-444. |
This work is licensed under a Creative Commons Attribution 3.0 License.
Copyright © Editorial Department of Cancer Prevention Research 鄂公网安备 42011102005013号 鄂ICP备2022015867号
Supported by: Beijing Renhe Information Technology Co., Ltd. 
DownLoad: